Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B vaccination in children: five year booster study.

A Milne1, S Krugman, J A Waldon

  • 1Hepatitis Research Unit, Whakatane, New Zealand.

The New Zealand Medical Journal
|August 26, 1992
PubMed
Summary

Hepatitis B vaccination in children provides protection for at least five years. Booster doses are not needed within this timeframe if initial vaccine response is strong, aiding hepatitis B control in endemic regions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rodent home cage monitoring for preclinical safety pharmacology assessment: results of a multi-company validation evaluating nonclinical and clinical data from three compounds.

Frontiers in toxicology·2025
Same author

Cereal grain mineral micronutrient and soil chemistry data from GeoNutrition surveys in Ethiopia and Malawi.

Scientific data·2022
Same author

Establishing a baseline for a national paediatric antimicrobial stewardship programme.

The Journal of antimicrobial chemotherapy·2019
Same author

The eastern extent of seasonal iron limitation in the high latitude North Atlantic Ocean.

Scientific reports·2019
Same author

Care of Women with Obesity in Pregnancy: Green-top Guideline No. 72.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Results from the third Scottish National Prevalence Survey: is a population health approach now needed to prevent healthcare-associated infections?

The Journal of hospital infection·2018

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern, particularly in endemic areas.
  • Effective vaccination strategies are crucial for controlling HBV transmission in pediatric populations.

Purpose of the Study:

  • To assess the duration of protective immunity conferred by hepatitis B vaccines in children.
  • To determine the necessity of booster doses within five years post-primary immunization.

Main Methods:

  • A cohort of 318 children received a 2-microgram intramuscular dose of recombinant DNA vaccine (rDNAV).
  • These children had previously received plasma-derived vaccine (PDV) doses five years prior.
  • Hepatitis B virus (HBV) seromarkers were analyzed pre- and post-booster administration.

Related Experiment Videos

Main Results:

  • All children demonstrated an anamnestic response to the booster dose.
  • The geometric mean titre (GMT) of antibody to hepatitis B surface antigen (antiHBs) significantly increased from 89 to 4777 IU/L.
  • Antibody detection rates were high, with 94% positive before the booster and 96.5% positive shortly after.

Conclusions:

  • Satisfactory initial seroconversion indicates sustained protection for at least five years.
  • Booster doses for hepatitis B are not required for children within five years if primary immunization is successful.
  • These findings support simplified hepatitis B vaccination schedules for population control in endemic regions.